<DOC>
	<DOCNO>NCT00188708</DOCNO>
	<brief_summary>Prostate cancer , common many tumour , often hypoxic ; , low level oxygen . It think tumour hypoxia may hasten progression cancer make resistant treatment . One previous study suggest hormone therapy , Casodex , may improve prostate oxygen level . This study design test finding .</brief_summary>
	<brief_title>Effect Casodex Tumour Hypoxia - Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Bicalutamide</mesh_term>
	<criteria>Men histologically proven prostatic carcinoma , stage cT2 , N0 , M0 , receive neoadjuvant bicalutamide plus conformal radiotherapy study 9907 , previously participate prostate cancer hypoxia project inform consent Coagulopathy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>